Pasquale Lombardi

Closest collaborators

The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Francesco Leone · 4 shared papers, 2019–2020 · strength 0.39
   • Paper Corrigendum to ""Shades of Gray" in pancreatic ductal adenocarcinoma: Reappraisals on resectability criteria: Debated i… DOI 10.1016/j.critrevonc.2020.102867↗
   • Paper "Shades of Gray" in pancreatic ductal adenocarcinoma: Reappraisals on resectability criteria: Debated indications for s… DOI 10.1016/j.critrevonc.2018.10.009↗
   • Paper Is There a Standard Adjuvant Therapy for Resected Pancreatic Cancer? DOI 10.3390/cancers11101547↗
2. Massimo Aglietta · 4 shared papers, 2019–2020 · strength 0.39
   • Paper Corrigendum to ""Shades of Gray" in pancreatic ductal adenocarcinoma: Reappraisals on resectability criteria: Debated i… DOI 10.1016/j.critrevonc.2020.102867↗
   • Paper "Shades of Gray" in pancreatic ductal adenocarcinoma: Reappraisals on resectability criteria: Debated indications for s… DOI 10.1016/j.critrevonc.2018.10.009↗
   • Paper Is There a Standard Adjuvant Therapy for Resected Pancreatic Cancer? DOI 10.3390/cancers11101547↗
3. Elisabetta Fenocchio · 1 shared paper, 2019 · strength 0.10
   • Paper Is There a Standard Adjuvant Therapy for Resected Pancreatic Cancer? DOI 10.3390/cancers11101547↗
4. Déwi Vernerey · 1 shared paper, 2019 · strength 0.07
   • Paper Validated Nomogram Predicting 6-Month Survival in Pancreatic Cancer Patients Receiving First-Line 5-Fluorouracil, Oxali… DOI 10.1016/j.clcc.2019.08.004↗
5. Cindy Neuzillet · 1 shared paper, 2019 · strength 0.07
   • Paper Validated Nomogram Predicting 6-Month Survival in Pancreatic Cancer Patients Receiving First-Line 5-Fluorouracil, Oxali… DOI 10.1016/j.clcc.2019.08.004↗
6. Caterina Vivaldi · 1 shared paper, 2019 · strength 0.07
   • Paper Validated Nomogram Predicting 6-Month Survival in Pancreatic Cancer Patients Receiving First-Line 5-Fluorouracil, Oxali… DOI 10.1016/j.clcc.2019.08.004↗
7. Angélique Vienot · 1 shared paper, 2019 · strength 0.07
   • Paper Validated Nomogram Predicting 6-Month Survival in Pancreatic Cancer Patients Receiving First-Line 5-Fluorouracil, Oxali… DOI 10.1016/j.clcc.2019.08.004↗
8. Alessandro Passardi · 1 shared paper, 2019 · strength 0.07
   • Paper Validated Nomogram Predicting 6-Month Survival in Pancreatic Cancer Patients Receiving First-Line 5-Fluorouracil, Oxali… DOI 10.1016/j.clcc.2019.08.004↗
9. Astrid Lièvre · 1 shared paper, 2019 · strength 0.07
   • Paper Validated Nomogram Predicting 6-Month Survival in Pancreatic Cancer Patients Receiving First-Line 5-Fluorouracil, Oxali… DOI 10.1016/j.clcc.2019.08.004↗
10. Rosella Spadi · 1 shared paper, 2019 · strength 0.07
    • Paper Validated Nomogram Predicting 6-Month Survival in Pancreatic Cancer Patients Receiving First-Line 5-Fluorouracil, Oxali… DOI 10.1016/j.clcc.2019.08.004↗
11. Lorenzo Fornaro · 1 shared paper, 2019 · strength 0.07
    • Paper Validated Nomogram Predicting 6-Month Survival in Pancreatic Cancer Patients Receiving First-Line 5-Fluorouracil, Oxali… DOI 10.1016/j.clcc.2019.08.004↗
12. Francesco Montagnani · 1 shared paper, 2019 · strength 0.07
    • Paper Validated Nomogram Predicting 6-Month Survival in Pancreatic Cancer Patients Receiving First-Line 5-Fluorouracil, Oxali… DOI 10.1016/j.clcc.2019.08.004↗
13. Julien Edeline · 1 shared paper, 2019 · strength 0.07
    • Paper Validated Nomogram Predicting 6-Month Survival in Pancreatic Cancer Patients Receiving First-Line 5-Fluorouracil, Oxali… DOI 10.1016/j.clcc.2019.08.004↗
14. Enrico Vasile · 1 shared paper, 2019 · strength 0.07
    • Paper Validated Nomogram Predicting 6-Month Survival in Pancreatic Cancer Patients Receiving First-Line 5-Fluorouracil, Oxali… DOI 10.1016/j.clcc.2019.08.004↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.